Biovault Technical
Biovault Technical is a leading provider of stem cell processing, tissue storage, and biobanking services, committed to industry standards and innovation. Established in 2002, it supports healthcare and research sectors with a focus on quality, safety, and ethical practices. The company is accredited by HTA, JACIE, and MHRA, and works in full accordance with GDP, serving both public and private sector clients globally.
Industries
Nr. of Employees
small (1-50)
Biovault Technical
Plymouth, Plymouth, United Kingdom, Europe
Products
Allograft tissue supply for surgery
A portfolio of tested and licensed human allograft tissues for surgical use, including bone, tendon, meniscal, ocular, cardiothoracic and demineralized bone matrix products, stored and released under regulated conditions.
Allograft tissue supply for surgery
A portfolio of tested and licensed human allograft tissues for surgical use, including bone, tendon, meniscal, ocular, cardiothoracic and demineralized bone matrix products, stored and released under regulated conditions.
Services
Processing, storage and release workflows for cellular therapy products including peripheral blood stem cell (PBSC) products and support for ATMPs, with documented handling and release processes.
Secure storage solutions for ATMPs, tissues and DNA across multiple temperature regimes, with continuous monitoring, inventory control and logistics support for research and clinical use.
Import, storage, testing and distribution of a comprehensive range of allograft tissues for surgical applications, managed under appropriate regulatory licences and quality systems.
Tailored advisory services covering regulatory interpretation, QMS design, validation, environmental monitoring, cleanroom design, designated individual services and import/export guidance.
Development and provision of contingency strategies, temporary processing/storage solutions and resilience planning to maintain operations during unexpected events or planned changes.
Operational support including environmental monitoring systems, secure LIMS data backup arrangements and GDP courier coordination for sample movement.
Processing, storage and release workflows for cellular therapy products including peripheral blood stem cell (PBSC) products and support for ATMPs, with documented handling and release processes.
Secure storage solutions for ATMPs, tissues and DNA across multiple temperature regimes, with continuous monitoring, inventory control and logistics support for research and clinical use.
Import, storage, testing and distribution of a comprehensive range of allograft tissues for surgical applications, managed under appropriate regulatory licences and quality systems.
Tailored advisory services covering regulatory interpretation, QMS design, validation, environmental monitoring, cleanroom design, designated individual services and import/export guidance.
Development and provision of contingency strategies, temporary processing/storage solutions and resilience planning to maintain operations during unexpected events or planned changes.
Operational support including environmental monitoring systems, secure LIMS data backup arrangements and GDP courier coordination for sample movement.
Expertise Areas
- Biobanking and biorepository management
- Cellular therapy processing and product release (including PBSC and ATMPs)
- Allograft importation, storage and surgical supply
- Contingency planning and business continuity for biological materials
Key Technologies
- ISO-classified cleanrooms (ISO 5–8)
- Cryogenic storage systems (< -150°C)
- Ultra-low temperature freezers (-60°C to -86°C)
- Cold chain and GDP-compliant courier logistics
News & Updates
Discover why Biovault is the trusted partner for cellular therapy processing and tissue banking.
The MHRA has granted Biovault Technical a WDA license, enabling the distribution of medicinal products and advancing cell therapy access in Plymouth and the UK.
Biovault will support the South West Peninsula Transplant Service in bringing CAR-T treatments to patients in Cornwall and Devon, with plans to extend licensing to handle prescription-only medications.
Trends in CAR-T, JACIE developments, and the growing demand for contingency services in cell therapy.
Biovault provides reliable assays to ensure accurate CFU/gm testing for cell quality.
Lab-grown stem cells may revolutionise cancer treatment by reducing the need for donors.
Discover why Biovault is the trusted partner for cellular therapy processing and tissue banking.
The MHRA has granted Biovault Technical a WDA license, enabling the distribution of medicinal products and advancing cell therapy access in Plymouth and the UK.
Biovault will support the South West Peninsula Transplant Service in bringing CAR-T treatments to patients in Cornwall and Devon, with plans to extend licensing to handle prescription-only medications.
Trends in CAR-T, JACIE developments, and the growing demand for contingency services in cell therapy.
Biovault provides reliable assays to ensure accurate CFU/gm testing for cell quality.
Lab-grown stem cells may revolutionise cancer treatment by reducing the need for donors.